METROPOLITAN LIFE INSURANCE CO/NY - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$25,348
-8.2%
28,609
+62.7%
0.00%0.0%
Q3 2022$27,602
-40.5%
17,581
-23.8%
0.00%
-50.0%
Q2 2022$46,395
+3.8%
23,082
+20.3%
0.00%0.0%
Q1 2022$44,692
-87.6%
19,181
-75.2%
0.00%
-60.0%
Q4 2021$360,082
-35.3%
77,437
+6.2%
0.01%
-37.5%
Q3 2021$556,227
-21.8%
72,900
-0.7%
0.01%
-20.0%
Q2 2021$711,430
+27.2%
73,419
+8.6%
0.01%
+25.0%
Q1 2021$559,184
+14.5%
67,616
-5.5%
0.01%
+14.3%
Q4 2020$488,199
-32.1%
71,531
+10.9%
0.01%
-46.2%
Q3 2020$719,142
+109.2%
64,497
+17.8%
0.01%
+116.7%
Q2 2020$343,773
+325.6%
54,741
+24.7%
0.01%
+200.0%
Q1 2020$80,783
-44.1%
43,904
+2.8%
0.00%0.0%
Q4 2019$144,400
+244.4%
42,722
+118.1%
0.00%
+100.0%
Q3 2019$41,925
-52.6%
19,591
-40.9%
0.00%0.0%
Q2 2019$88,476
-43.8%
33,1370.0%0.00%
-66.7%
Q1 2019$157,401
+117.1%
33,137
+9.7%
0.00%
+200.0%
Q4 2018$72,506
-45.5%
30,2110.0%0.00%
-50.0%
Q3 2018$132,928
-99.9%
30,2110.0%0.00%
-50.0%
Q2 2018$217,519,000
+163448.1%
30,211
+21.8%
0.00%
+300.0%
Q1 2016$133,000
-24.4%
24,810
+22.6%
0.00%0.0%
Q4 2015$176,000
+3.5%
20,2410.0%0.00%0.0%
Q3 2015$170,000
-53.9%
20,241
-3.4%
0.00%
-66.7%
Q2 2015$369,00020,9490.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders